ID: ALA1257231

Max Phase: Preclinical

Molecular Formula: C18H33NO3

Molecular Weight: 311.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC/C(CCCCC/C=C\CCCCCCCC(=O)O)=N/O

Standard InChI:  InChI=1S/C18H33NO3/c1-2-17(19-22)15-13-11-9-7-5-3-4-6-8-10-12-14-16-18(20)21/h3,5,22H,2,4,6-16H2,1H3,(H,20,21)/b5-3-,19-17-

Standard InChI Key:  MGXBHDJXVAWBPH-LULARPCESA-N

Associated Targets(non-human)

Mannheimia haemolytica 42 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Pasteurella multocida 1166 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Actinobacillus pleuropneumoniae 73 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Histophilus somni 12 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 311.47Molecular Weight (Monoisotopic): 311.2460AlogP: 5.55#Rotatable Bonds: 15
Polar Surface Area: 69.89Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.99CX Basic pKa: 3.03CX LogP: 5.53CX LogD: 3.23
Aromatic Rings: 0Heavy Atoms: 22QED Weighted: 0.14Np Likeness Score: 0.71

References

1. Watanabe T, Kurata I, Hayashi C, Igarashi M, Sawa R, Takahashi Y, Akamatsu Y..  (2010)  The synthesis of paleic acid, an antimicrobial agent effective against Mannheimia and Pasteurella, and its structurally related derivatives.,  20  (19): [PMID:20728353] [10.1016/j.bmcl.2010.07.115]

Source